Health

The city’s health commissioner said vaccinating children under 5 will help slow the spread, and the city will be ready when federal regulators give the green light.

Many families with low incomes who want their children to keep learning remotely are losing access to a federal program that helped them pay for meals.

NPR has obtained the government's $5.3 million contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

The first big hurdle was crossed when Pfizer shared its clinical trial data with the FDA. There are five more steps before this vulnerable population can be vaxxed.

Use of xylazine, a horse tranquilizer, leads to wounds that are very difficult to treat.

The move could open the way for the very youngest Americans to start receiving shots by early March.

The weekly average of new daily cases has plummeted by 74% since Delaware’s indoor mask mandate went into effect. Hospitalizations are down by half.

A federal court filing made Tuesday in Cleveland lays out the details of the settlements with drugmaker Johnson & Johnson and distribution companies.

90 million cases of coronavirus have been reported since the omicron variant was first identified 10 weeks ago — amounting to more than in all of 2020.

For some, getting a positive test could mean loss of income. Doctors worry about growing disincentives to test and how this could prolong the pandemic.

The FDA is pushing the company to submit its application based on the two-dose data for potential approval in February.

The temporary sites, one of which will be located in Philadelphia, will allow hospitals to more rapidly discharge patients in need of long-term care.

Coronavirus cases are dropping, but Delaware hospitals are still operating under crisis standards of care. “COVID is still deadly,” one nurse manager stressed.

Brandywine and Jennersville hospitals are now both closed. A new task force aims to keep services going, while another group wants the courts to intervene.

Full approval means FDA has completed the same rigorous, time-consuming review for Moderna’s shot as dozens of other long-established vaccines.